Pharma BD Deal Intelligence

Celera Genomics Group / Axys Pharmaceuticals Inc.

2001 · Acquisition/Merger · $173M · Complete

Stock-for-stock ~$174M at $4.65/Axys share. Strategic pivot for Celera into therapeutics/drug discovery.

Key facts

• Announced Nov 16, 2001
• Deal value $173M
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals